Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
2,027 articles
Aventura Private Wealth LLC Buys Shares of 3,861 Eli Lilly and Company $LLY
Aventura Private Wealth LLC bought a new position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) during the 4th quarter, according...
Aventura Private Wealth LLC Buys Shares of 3,861 Eli Lilly and Company $LLY
Aventura Private Wealth LLC bought a new position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) during the 4th quarter, according...
180 Wealth Advisors LLC Acquires 6,535 Shares of Amgen Inc. $AMGN
180 Wealth Advisors LLC raised its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 63.2% during the fourth quarter, according to the...
180 Wealth Advisors LLC Acquires 6,535 Shares of Amgen Inc. $AMGN
180 Wealth Advisors LLC raised its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 63.2% during the fourth quarter, according to the...
Cardinal Health, Inc. (NYSE:CAH) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Cardinal Health, Inc. (NYSE:CAH – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the...
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Rating of “Moderate Buy” by Brokerages
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twelve...
LivaNova PLC (NASDAQ:LIVN) Receives Consensus Rating of “Moderate Buy” from Brokerages
LivaNova PLC (NASDAQ:LIVN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten ratings firms...
Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the...
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have earned a consensus rating of “Moderate Buy” from the ten...
Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives Consensus Rating of “Buy” from Analysts
Scholar Rock Holding Corporation (NASDAQ:SRRK – Get Free Report) has been assigned a consensus rating of “Buy” from the seventeen...
Solid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Rating of “Moderate Buy” by Brokerages
Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) has received an average recommendation of “Moderate Buy” from the twelve...
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of “Buy” from Brokerages
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA – Get Free Report) has been assigned an average recommendation of “Buy”...
Immuneering Corporation (NASDAQ:IMRX) Given Average Rating of “Moderate Buy” by Analysts
Shares of Immuneering Corporation (NASDAQ:IMRX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the seven...
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eleven...
FY2029 Earnings Estimate for Genelux Issued By HC Wainwright
Genelux Corporation (NASDAQ:GNLX – Free Report) – Stock analysts at HC Wainwright increased their FY2029 EPS estimates for Genelux in a...
Align Technology, Inc. (NASDAQ:ALGN) Receives $198.08 Consensus Target Price from Brokerages
Align Technology, Inc. (NASDAQ:ALGN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the fourteen...
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives $29.50 Average Target Price from Brokerages
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has earned an average rating of “Moderate Buy” from the...
Top Pharmaceutical Stocks To Research – March 21st
Abbott Laboratories, AbbVie, Eli Lilly and Company, Bristol Myers Squibb, and Gilead Sciences are the five Pharmaceutical stocks to watch today,...
Top Pharmaceutical Stocks To Research – March 21st
Abbott Laboratories, AbbVie, Eli Lilly and Company, Bristol Myers Squibb, and Gilead Sciences are the five Pharmaceutical stocks to watch today,...
Zacks Research Has Bullish Estimate for PLX FY2026 Earnings
Protalix BioTherapeutics, Inc. (NYSE:PLX – Free Report) – Analysts at Zacks Research boosted their FY2026 earnings estimates for shares...
📰
CoaguSense Announces Agreement to Acquire DOASENSE DOAC Testing Business, Expanding Leadership in Anticoagulation Monitoring
FREMONT, Calif., March 22, 2026 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a leading developer of point-of-care coagulation monitoring systems and a...
Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients
SHANGHAI, March 23, 2026 /PRNewswire/ -- Belief BioMed ("BBM") and Grand Life Sciences Group Co., Ltd. ("Grand Life Sciences") today announced an...
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Receives $22.25 Consensus PT from Brokerages
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the nine...
Analysts Offer Predictions for electroCore FY2030 Earnings
electroCore, Inc. (NASDAQ:ECOR – Free Report) – Equities researchers at HC Wainwright lifted their FY2030 earnings per share estimates...
Analysts Set Zura Bio Limited (NASDAQ:ZURA) Price Target at $11.60
Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven analysts that are...
Q3 EPS Estimates for Gossamer Bio Boosted by HC Wainwright
Gossamer Bio, Inc. (NASDAQ:GOSS – Free Report) – Equities researchers at HC Wainwright lifted their Q3 2026 earnings per share (EPS)...
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Receives $9.00 Consensus Target Price from Analysts
Shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six...
HC Wainwright Has Positive Forecast for Valneva Q3 Earnings
Valneva SE Sponsored ADR (NASDAQ:VALN – Free Report) – Stock analysts at HC Wainwright lifted their Q3 2026 earnings per share (EPS)...
Q1 EPS Estimate for Precision BioSciences Raised by Analyst
Precision BioSciences, Inc. (NASDAQ:DTIL – Free Report) – Stock analysts at HC Wainwright raised their Q1 2026 earnings per share (EPS)...
Q1 EPS Estimate for Aclaris Therapeutics Raised by Analyst
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Analysts at HC Wainwright boosted their Q1 2026 EPS estimates for shares of...
Sidoti Brokers Increase Earnings Estimates for Cibus
Cibus, Inc. (NASDAQ:CBUS – Free Report) – Equities research analysts at Sidoti upped their Q1 2026 earnings estimates for shares of Cibus...
What is Zacks Research’s Forecast for CPRX Q1 Earnings?
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) – Equities researchers at Zacks Research increased their Q1 2026 earnings per...
📰
HUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in China
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 23, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)...
📰
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition
Masimo develops advanced noninvasive monitoring technologies used by hospitals and healthcare providers worldwide.
📰
Prediction: The "Trough of Disillusionment" Will Create the Best Buying Opportunity for Artificial Intelligence (AI) Stocks in 2026
The sweeping correction that most of these stocks have suffered was not only predictable, but it also reliably precedes a better-supported recovery.
📰
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?
Olema Pharmaceuticals develops targeted therapies for women's cancers, with a lead program advancing in clinical trials for breast cancer.
📰
Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares?
HeartFlow delivers AI-powered, non-invasive cardiac diagnostics to healthcare providers seeking advanced imaging and decision support tools.